Neurology News and Research

Latest Neurology News and Research

A mind-reading machine could be reality soon

Scientists at the University of California at Berkeley have devised a method by which they can hear thoughts. They conducted a small study in which they could predict what people were thinking based on their brain activity.

1 Feb 2012

Decaffeinated coffee may improve brain energy metabolism linked with type 2 diabetes

Researchers from Mount Sinai School of Medicine have discovered that decaffeinated coffee may improve brain energy metabolism associated with type 2 diabetes.

1 Feb 2012

RMC first in N.J. to offer TESSYS minimally invasive surgery for patients with herniated discs

Riverview Medical Center, part of Meridian Neuroscience, today announced it is the only hospital in the state of New Jersey to offer patients the TESSYS surgery method, a minimally invasive procedure for the treatment of herniated discs.

1 Feb 2012

Biogen Idec 2011 total revenues increase 7% to $5.0 billion

Biogen Idec Inc., a global biotechnology leader in the discovery, development, manufacturing and commercialization of innovative therapies, today announced its full year and fourth quarter 2011 results.

1 Feb 2012

For stroke prevention, large medical centers may have the edge

Despite advances in the diagnosis and treatment of unruptured brain aneurysms, outcomes have remained stagnant over the last 10 years. This can be explained by the dramatic proliferation of minimally invasive endoscopic coiling procedures at lower-volume community hospitals, where outcomes are inferior.

30 Jan 2012

Mystery teen neurological illness followed up by Erin Brockovich meets resistance

Famous environmental activist Erin Brockovich’s team faced resistance as they tried to test the area around an upstate New York school for clues to a case involving more than a dozen teens plagued by mysterious Tourette's-like symptoms and seizures. One neurologist who has seen most of the affected girls has diagnosed their illness as psychological in origin, but some parents and members of the community have disputed that diagnosis.

30 Jan 2012

Covidien Solitaire FR Revascularization Device approved for investigational use

Covidien, a leading global provider of healthcare products, today announced that the Solitaire™ FR Revascularization Device has been approved for investigational use in the Interventional Management of Stroke (IMS III) trial.

30 Jan 2012

Valeant withdraws ISTA acquisition offer

Valeant Pharmaceuticals International, Inc. today announced that it has withdrawn its offer to acquire ISTA Pharmaceuticals Inc. for $7.50 per share in cash.

30 Jan 2012

Researchers develop new MRS technique to diagnose brain tumors

Researchers at UT Southwestern Medical Center have developed what they believe to be the first clinical application of a new imaging technique to diagnose brain tumors.

30 Jan 2012

Link between genetic abnormalities and cerebral palsy

For years it was thought that a difficult birth and other perinatal factors were the leading causes of cerebral palsy (CP), a group of disorders that can involve brain and nervous system functions such as movement, learning, hearing, seeing and thinking. Now, researchers at Geisinger Health System find that the majority of cerebral palsy causes may in fact be caused by genetic abnormalities.

27 Jan 2012

Boehringer Ingelheim initiates two afatinib phase III trials in head and neck cancer

Boehringer Ingelheim announced today the initiation of two phase III clinical trials, LUX-Head & Neck 1 and LUX-Head & Neck 2. These trials evaluate afatinib in patients with metastatic and recurrent head and neck cancer, and in patients with locally advanced disease, respectively.

27 Jan 2012

Breakthroughs in Alzheimer’s disease research

Researchers are closer to understanding Alzheimer’s disease using a new stem cell technique. They have successfully replicated Alzheimer’s disease neurons with stem cells for the first time.

26 Jan 2012

Magic Mushroom’s compound may help in some mental disorders: Study

There has been little research on the mechanism of action of “magic mushrooms” on the brain. A growing number of studies suggested that perhaps the mushrooms' key ingredient could work magic for certain mental disorders. New research in Proceedings of the National Academy of Sciences sheds light on why one of the mushrooms' hallucinogenic chemical compounds, psilocybin, may hold promise for the treatment of depression.

24 Jan 2012

Alzheimer’s disease may be kept at bay with regular brain stimulation: Study

A new study shows that regularly doing puzzles and reading books could be linked to a decreased risk of Alzheimer's disease. It says that these activities reduce the accumulation of harmful proteins in the brain.

24 Jan 2012

More efficient diagnostic tools are not always used for neuropathy patients

Researchers at the University of Michigan analyzed the tremendous cost of diagnosing peripheral neuropathy and found that less expensive, more effective tests are less likely to be used.

24 Jan 2012

Researchers analyze tremendous cost of peripheral neuropathy diagnosis

Researchers at the University of Michigan analyzed the tremendous cost of diagnosing peripheral neuropathy and found that less expensive, more effective tests are less likely to be used.

24 Jan 2012

UCSF-led study to sequence DNA from 4,000 people with epilepsy

To probe the genetic secrets of one of the most common neurological diseases, more than 4,000 people with various forms of epilepsy will have their DNA decoded over the next five years in a study led by researchers at the University of California, San Francisco (UCSF) and several collaborating institutions.

23 Jan 2012

Multiple sclerosis drug Gilenya under investigation by FDA and EMA

The US Food and Drugs Administration (FDA) and European Medicines Agency (EMA) are looking at the pros and cons of using Gilenya (fingolimod) in treating the neurological autoimmune disease Multiple Sclerosis (MS).

23 Jan 2012

FDA approves product label change for Biogen Idec's TYSABRI to treat MS

Today Biogen Idec and Elan Corporation, plc announced that the U.S. Food and Drug Administration (FDA) has approved a product label change for TYSABRI that will help enable individual benefit risk assessment for patients with multiple sclerosis.

21 Jan 2012

The AJMS publishes updates on type 2 diabetes, STIs

Research is leading to new insights on two major public health challenges: preventing the spread of sexually transmitted infections (STIs) and improving disease control for patients with type 2 diabetes. Expert updates on these critical topics appear in a special symposium section of the January issue of The American Journal of the Medical Sciences (The AJMS), official journal of the Southern Society for Clinical Investigation.

19 Jan 2012